Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000619

Drug Information
SynonymsNCGC00094887-02; SPBio_002707; 53746-45-5 (calcium salt, dihydrate); Fenoprofen calcium; Benzeneacetic acid, .alpha.-methyl-3-phenoxy-, (.+/-.)-; Spectrum2_001391; CHEMBL1297; AC1Q5RW1; 2-(3-Phenoxyphenyl)propanoic acid; HMS1921B19; HMS2090G18; HMS502K10; C06997; Spectrum4_001009; KBio1_000848; Lilly 53838; EINECS 250-850-3; 34597-40-5 (calcium salt, anhydrous); D02350; BRN 2118687; SPECTRUM1501011; Fenoprofene [INN-French]; KBio2_006868; Feneprofen calcium salt dihydrate; NINDS_000848; Prestwick0_000754; Spectrum3_000910; KBio3_001860; AB00052197; NCGC00094887-01; (+-)-2-(3-Phenoxyphenyl)propionic acid; HSDB 3328; UNII-RA33EAC7KY; KBio2_001732; Fenoprofeno; Feprona; DB00573; Hydratropic acid, m-phenoxy-, (+-)-; alpha-Methyl-3-phenoxybenzeneacetic acid; 29679-58-1; HMS2092B07; Nalgesic; Fenoprofen calcium hydrate; Spectrum_001252; EINECS 249-770-1; SPBio_001402; BPBio1_000846; Prestwick3_000754; Benzeneacetic acid, alpha-methyl-3-phenoxy-, (+-)-; 31879-05-7; Fenoprofen (USAN/INN); 95907-05-4; KBio2_004300; 2-(m-phenoxyphenyl)propionic acid; CID3342; (+-)-m-Phenoxyhydratropic acid; CHEBI:5004; Fenoprofenum [INN-Latin]; AR-1J0752; BSPBio_000768; KBioSS_001732; MolPort-003-666-345; Prestwick2_000754; DivK1c_000848; 2-[3-(phenyloxy)phenyl]propanoic acid; Nalfon; Fenoprofene; LS-76362; alpha-(m-phenoxyphenyl)propionic acid; 2-(3-Phenoxyphenyl)propionic acid; Spectrum5_001311; Fenoprofen Dihydrate, Calcium Salt; KBioGR_001477; Fenoprofen [USAN:BAN:INN]; Fenoprofenum; fenoprofen; Fenoprofeno [INN-Spanish]; AC1L1FPT; Prestwick1_000754; IDI1_000848    
Trade NameFenopron    
CompanyTypharm Limited    
IndicationRheumatoid arthritisApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAnti-Inflammatory Agents    
CAS NumberCAS 34597-40-5
PubChem Compound IDCID 3342.    
PubChem Substance IDSID 9210.    
SuperDrug ATC IDM01AE04;    
SuperDrug CAS ID031879057;    
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 072267 To Reference
Ref 2The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res. 2007 Apr 1;67(7):3254-62. To Reference
Ref 3Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses. Arch Pharm Res. 2007 Jan;30(1):64-74. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543